We are live on ! Find out more
CCXI

ChemoCentryx, Inc.

Delisted

CCXI was delisted on the 19th of October, 2022.

65 hedge funds and large institutions have $163M invested in ChemoCentryx, Inc. in 2015 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

46% more call options, than puts

Call options by funds: $328K | Put options by funds: $225K

10% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 20

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

7% less funds holding

Funds holding: 7065 (-5)

25% less capital invested

Capital invested by funds: $216M → $163M (-$53.3M)

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
65
Holders Change
-5
Holders Change %
-7.14%
% of All Funds
1.81%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.03%
New
4
Increased
22
Reduced
20
Closed
9
Calls
$328K
Puts
$225K
Net Calls
+$103K
Net Calls Change
+$62K
Name Holding Trade Value Shares
Change
Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$519K -$208K -28,758 -25%
Ohio Public Employees Retirement System (OPERS)
27
Ohio Public Employees Retirement System (OPERS)
Ohio
$453K
California Public Employees Retirement System
28
California Public Employees Retirement System
California
$380K
Millennium Management
29
Millennium Management
New York
$367K -$82.6K -11,428 -16%
RA
30
Royce & Associates
New York
$333K -$108K -15,000 -21%
BPC
31
Banque Pictet & Cie
Switzerland
$328K -$129K -17,782 -25%
California State Teachers Retirement System (CalSTRS)
32
California State Teachers Retirement System (CalSTRS)
California
$308K -$1.45K -200 -0.4%
BCM
33
Bridgeway Capital Management
Texas
$303K
BBA
34
Baker Bros. Advisors
New York
$297K
TA
35
Teachers Advisors
New York
$247K
KeyBank National Association
36
KeyBank National Association
Ohio
$232K
ProShare Advisors
37
ProShare Advisors
Maryland
$220K -$15.6K -2,160 -6%
Charles Schwab
38
Charles Schwab
California
$212K
RhumbLine Advisers
39
RhumbLine Advisers
Massachusetts
$160K +$6.63K +917 +4%
New York State Common Retirement Fund
40
New York State Common Retirement Fund
New York
$154K -$38.6K -5,340 -17%
Renaissance Technologies
41
Renaissance Technologies
New York
$149K -$742K -102,677 -81%
DekaBank Deutsche Girozentrale
42
DekaBank Deutsche Girozentrale
Germany
$133K +$7.23K +1,000 +5%
PBT
43
Pictet Bank & Trust
Bahamas
$127K +$152K +21,028 New
NFA
44
Nationwide Fund Advisors
Ohio
$113K
Goldman Sachs
45
Goldman Sachs
New York
$103K +$123K +16,976 New
AIG
46
American International Group
New York
$99K +$137 +19 +0.1%
Wells Fargo
47
Wells Fargo
California
$96K +$3.85K +532 +3%
BA
48
BlackRock Advisors
Delaware
$81K -$9.67K -1,337 -9%
VOYA Investment Management
49
VOYA Investment Management
Georgia
$79K
Morgan Stanley
50
Morgan Stanley
New York
$78K -$208K -28,785 -69%

CCXI Hedge Fund Activity: Q3 2015 in Review

65 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in ChemoCentryx, Inc. (CCXI) for Q3 2015, worth a combined $163M — down 25% from $216M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of CCXI and 4 opened new positions — a net loss of 5 holders — while 20 trimmed existing stakes and 22 added.

The largest buyer was BVF Inc, adding an estimated $2.19M. The largest seller was Renaissance Technologies, cutting an estimated $742K.

  • 65 institutional investors held ChemoCentryx, Inc. (CCXI) as of Q3 2015, down from 70 in Q2 2015.
  • Funds reported $163M of ChemoCentryx, Inc. stock for Q3 2015, down 25% quarter-over-quarter.
  • 4 funds opened new ChemoCentryx, Inc. positions in Q3 2015 and 9 closed out, a net change of -5 holders.
  • The largest ChemoCentryx, Inc. buyer in Q3 2015 was BVF Inc, an estimated $2.19M added.
  • The largest ChemoCentryx, Inc. seller in Q3 2015 was Renaissance Technologies, an estimated $742K sold.

Based on aggregated 13F filings for Q3 2015.